TAG1 And NRG Pallas Sign Agreement On Next-Generation Cancer Therapies
Aim is to deliver significant quantities of Pb-212 to drug innovators across Europe
Pb-212
UK / Scientists Make Breakthrough In Production Of Crucial Medical Radioisotope
Lead-212 used in target cancer therapy
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
© 2026 NucNet. All Rights Reserved.